Drugs that modify DNA structure may be beneficial for treating Alzheimer's disease

In a study published in Nature Neuroscience, Bess Frost, PhD, and co-authors, identify abnormal expression of genes, resulting from DNA relaxation, that can be detected in the brain and blood of Alzheimer’s patients.The protein tau is involved in a number of neurodegenerative disorders, including Alzheimer’s disease. Read & Research Alzheimer’s More

Leave a Reply